Lux Ventures IV, L.P.

Other

US·SEC (Form 4)

Latch, Inc.Recursion Pharmaceuticals, INC.

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the complete record of transactions filed by Lux Ventures IV, L.P.. Officer active across 2 companies, notably Latch, Inc.. Aggregated, 4 reports have been recorded. The latest transaction was disclosed on 7 December 2021 — J. Regulator: SEC (Form 4). All data is accessible without signup.

Declarations4 total

Executives●JRRecursion Pharmaceuticals, INC.3SEC

L

Lux Ventures IV, L.P.

04,265,576 shares0

Class A common stock

SEC:0000905718-21-001582·7 Dec 2021

SEC ↗

Executives●JRRecursion Pharmaceuticals, INC.2SEC

L

Lux Ventures IV, L.P.

04,265,576 shares0